The Week In Cannabis: Trulieve’s $2.1B Acquisition, New ETF, Earnings, Federal Legalization And More
In a week of big M&A news and mixed earnings reports, cannabis stocks traded mostly down.
Sundial Growers Nears The End Of A Pattern … A Break Potentially Moves It Higher
Sundial Growers Inc. (NASDAQ: SNDL) shares gapped up Wednesday morning and have since fallen after the company released its earnings report Tuesday.
Sundial Q1 2021 Adj EBITDA $3.3M
Earnings from operations of $1.7 million compared to a loss from operations of $32.7 million in the prior quarter.
Net loss of $134.4 million as a result of $130.0
Earnings Scheduled For May 11, 2021
Companies Reporting Before The Bell
• Oxford Lane Capital (NASDAQ:OXLC) is estimated to report earnings for its fourth quarter.
Canadian Cannabis Producers Are Dependent On Value Flower: Analyst
Canadian licensed cannabis producers have been faced with challenges imposed by ongoing price deflation, COVID-19 lockdowns and uncertainty over whether and when U.S. federal legalization will occur.
As a result, some Canadian cannabis companies have become dependent on value flower, according to a Cantor Fitzgerald analyst.
Sundial Growers Resumes Downtrend
After two weeks of consolidating below resistance at the one dollar level, shares of Reddit favorite Sundial Growers Inc. (NASDAQ: SNDL) have resumed their downtrend.
Video: Benzinga Cannabis Insider 5/04 Ft. Aurora, Tilray, Sundial, Hydrofarm & More
Benzinga’s Cannabis Insider is a live daily show for cannabis investors.
Cannabis Stock Gainers And Losers From May 3, 2021
GAINERS:
Rhinomed (OTC: RHNMF) shares closed up 55.92% at $0.16
9 Health Care Stocks Showing Unusual Options Activity In Today’s Session
This unusual options alert can help traders track potentially big trading opportunities. Traders often look for circumstances when the market estimation of an option diverges away from its normal worth. Unusual trading activity could push option prices to hyperbolic or underperforming levels.
Cannabis Stock Gainers And Losers From April 30, 2021
GAINERS:
Rhinomed (OTC: RHNMF) shares closed up 106% at $0.10